MAEVE GARCIA: Open Payments
NPI 1457076762 · SOUTHLAKE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,423 in 88 payments from 14 companies in 2025. Trend: 2023 $690 · 2024 $1,256 · 2025 $1,423
Food & beverage: $1,423
| Company | Payments | Amount |
|---|---|---|
| Forte Bio-Pharma LLC | 30 | $543 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $187 |
| PFIZER INC. | 17 | $150 |
| Boston Scientific Corporation | 3 | $100 |
| Collegium Pharmaceutical, Inc. | 5 | $86 |
| SCILEX PHARMACEUTICALS INC. | 5 | $86 |
| SI-BONE, INC. | 2 | $48 |
| Saluda Medical Americas, Inc. | 5 | $47 |
| ABBVIE INC. | 2 | $41 |
| Azurity Pharmaceuticals, Inc. | 2 | $36 |
Products named: PROLATE, RELISTOR, NURTEC ODT, XTAMPZA, ELYXYB - CELECOXIB, Evoke, Clinical Trial Product, HORIZANT.
Industry payments across TX — which companies pay providers there.
